Rhythm Biosciences appoints Dr. David Atkins as Chief Executive Officer
SYDNEY: Rhythm Biosciences Ltd (ASX: RHY) announced the appointment of Dr. David Atkins as Chief Executive Officer (CEO) effective from Monday, 13 May 2024. Dr. Atkins was selected following a comprehensive and competitive search, which considered both experienced and highly…